With Strong Q3 Financials, Pfizer Says It's Ready For Generic Competition To Lipitor

The world's largest pharma highlights sales growth of Prevnar 13, Enbrel and Lyrica, emerging markets growth, and a developing plan to sell off animal health and nutritional units.